--- title: "Dow 30 Earnings: DowDuPont First Quarter Fiscal 2018" description: dow 30, DowDuPont, first-quarter earnings, net sales of $21.5 billion, GAAP earnings per share of $0.47, adjusted share net of $1.12, Wall Street not impressed, stock lower this morning, strong performance of Materials Science division, healthy overall results from Specialty Products segment image: https://investor.valueline.com/hubfs/social-suggested-images/iStock-184958661-4.jpg --- [![The Value Line Blog](https://investor.valueline.com/hubfs/VL%20Blog%20Images/vl_blog_header.png)](https://investor.valueline.com/blog) [Stock Highlights](https://investor.valueline.com/blog/topic/stock-highlights) # Dow 30 Earnings: DowDuPont First Quarter Fiscal 2018 May 3, 2018 Diversified chemicals manufacturer and Dow-30 component **DowDuPont** ([DWDP](https://research.valueline.com/secure/research#sym=DWDP&list=dow30&sec=company)- [Free DowDuPont Stock Report](https://research.valueline.com/secure/api/report?documentID=2185-VL_20180406_VLIS_DWDP_25784_01-3K7I519HASRN5B2GAGQH5J312F&symbol=DWDP)) has reported first-quarter earnings. The company posted net sales of $21.5 billion, representing 5% growth, on a pro forma basis. This was driven by the healthy performance of a number of businesses within the Materials Science and Specialty Products segments. GAAP earnings per share was $0.47, and adjusted share net came in at $1.12. Efforts by the company to control expenses supported profitability. Wall Street was not impressed by the company’s latest round of results, however, sending the stock lower this morning. The Materials Science division experienced strong performances from all segments and regions. The Performance Materials & Coatings business enjoyed strength in Consumer Solutions. Meanwhile, the Industrial Intermediates & Infrastructure line gained from robust sales in Polyurethanes & CAV. Elsewhere, the Packaging & Specialty Plastics operation benefited from healthy volume growth and greater prices for ethylene derivatives. The Specialty Products segment also posted healthy overall results. The Nutrition & Biosciences line benefited from greater demand for probiotics and pharmaceuticals. The Transportation & Advanced Polymers unit also capitalized on healthy demand from a number of markets. Elsewhere, the Safety & Construction business gained from strength in industrial personal protection, graphics, and medical packaging markets. Performance was somewhat less favorable at the Electronics & Imaging operation, as modest volume growth was outweighed by the divestiture of several businesses. These increases more than offset weakness in the Agriculture segment, which experienced considerable volume declines. Results here were hurt by weather-related planting delays in North America and Brazil, lower-than- expected planting area, and a decline in sales during the Brazil safrinha season. This was partly offset by improvements in sunflower seeds in certain markets and growth in global insecticide sales. Looking forward, the company ought to further benefit from broad-based growth in the global economy in the coming quarters, driven by consumer-led demand. A number of leading indicators suggest increasing economic activity, and we expect that DowDuPont will further benefit from favorable macroeconomic trends. That said, volatility of input costs and weather-related softness in agriculture will likely remain headwinds. All things considered, we have decided to leave intact our expected full-year 2018 sales and share earnings estimates of $85 billion and $3.40, respectively. — Michael Napoli *At the time of this article’s writing, the author did not have positions in any of the companies mentioned.* [![Register now for our free One Stock to Buy webinar](https://no-cache.hubspot.com/cta/default/2532383/5a80130b-f0ce-4bd8-acbd-f077f2232ec5.png)](https://cta-redirect.hubspot.com/cta/redirect/2532383/5a80130b-f0ce-4bd8-acbd-f077f2232ec5) ### Popular Posts Search Search Blog ### Topics - [Investing 101 (2)](https://investor.valueline.com/blog/topic/investing-101) - [Market Commentary (37)](https://investor.valueline.com/blog/topic/market-commentary) - [Stock Highlights (390)](https://investor.valueline.com/blog/topic/stock-highlights) - [Stock Market Today (2071)](https://investor.valueline.com/blog/topic/stock-market-today) Copyright 2026 Value Line, Inc. All Rights Reserved. Factual material is obtained from sources believed to be reliable and is provided without warranties of any kind. VALUE LINE IS NOT RESPONSIBLE FOR ANY ERRORS OR OMISSIONS HEREIN OR ANY DAMAGES OR LOSSES ARISING FROM ANY USE OF THE INFORMATION CONTAINED HEREIN. This blog is strictly for subscriber's own, non-commercial, internal use. No part of it may be reproduced, stored or transmitted in any printed, electronic or other form, or used for generating or marketing any printed or electronic publication, service or product. Officers, directors, or employees of Value Line, Inc. and its affiliates and subsidiaries, and EULAV Asset Management, may own stocks that are featured in this email. Nothing herein should be construed as an offer to buy or sell securities or to give individual investment advice. Value Line, the Value Line logo, The Most Trusted Name in Investment Research, “Smart research. Smarter investing.”, The Value Line Investment Survey, Timeliness, and Safety are trademarks or registered trademarks of Value Line, Inc. and/or its affiliates in the United States and other countries.